Camrelizumab with chemotherapy improves overall survival in esophageal squamous cell carcinoma: JAMA MD Editorial Team22 Sept 2021 9:00 AM ISTChina: A recent study in JAMA pointed that an initial treatment of camrelizumab combined with chemotherapy when compared with placebo and...
New prediction model helps stratify death risk after esophagectomy for cancer: Study Dr. Shravani Dali21 Sept 2021 9:00 AM ISTThe IESG risk prediction model allowed stratification of an individual patient's risk of death within 90 days after esophagectomy, suggests a study...
Low doses of radioactive iodine for Hyperthyroidism has minimal cancer risk: JAMA Dr. Shravani Dali20 Sept 2021 9:15 AM ISTInsignificant risk of cancer is associated with low doses of Radioactive Iodine Treatment (RAI) therapy used for Hyperthyroidism, suggests a study ...
Eosinophils may help destroy malignant tumors, finds study Hina Zahid20 Sept 2021 9:00 AM ISTA new study at Tel Aviv University found that eosinophils - a type of white blood cells - are recruited to the battle against cancer metastases in the...
Preoperative dietary fiber intake tied to lower risk of complications after colorectal cancer surgery: JAMA Medha Baranwal20 Sept 2021 9:00 AM ISTNetherlands: Higher intake of habitual dietary fiber before surgery for colorectal cancer (CRC) lowers the risk of postoperative complications,...
Low dose CT screening for lung cancer reduces mortality, confirms meta - analysis Hina Zahid18 Sept 2021 9:00 AM ISTDenver - Low-dose CT lung cancer (LDCT) screening is associated with a 16 percent relative reduction in lung cancer mortality, when compared against a...
FDA approves first targeted oral therapy for very rare lung cancer Dr Kartikeya Kohli17 Sept 2021 9:39 AM ISTCAMBRIDGE, Mass - The U.S. Food and Drug Administration (FDA) has approved EXKIVITY (mobocertinib) for the treatment of adult patients with...
Patients treated with immune checkpoint inhibitors have better quality of life, finds study Dr. Kamal Kant Kohli16 Sept 2021 9:30 AM ISTResearchers compared self-reported outcomes of patients treated with and without immunotherapy
Perioperative flurbiprofen therapy is associated with survival benefit in esophageal cancer patients: Study Dr Nisanth Puliyath14 Sept 2021 9:00 AM ISTPerioperative use of a Non-Steroidal Anti Inflammatory Drug (NSAID) - flurbiprofen axetil is associated with prolonged recurrence free and overall...
Ranitidine does not increase risk of Gastric Cancer, finds study MD Editorial Team13 Sept 2021 9:00 AM ISTGastric cancer is one of the most common malignancies worldwide, with a significant death rate, particularly in East Asia. N-nitrosodimethylamine...
Researchers use deep learning to predict breast cancer risk Hina Zahid11 Sept 2021 9:33 AM ISTOAK BROOK, Ill. - Compared with commonly used clinical risk factors, a sophisticated type of artificial intelligence (AI) called deep learning does a...
Chemotherapy drug linked to high risk of hearing loss in young children with cancer Hina Zahid11 Sept 2021 9:00 AM ISTThe chemotherapy drug cisplatin is an effective cancer treatment for many children with cancer, but unfortunately it can cause permanent hearing loss....
